Furthermore, the differences in expression were significant, which suggested that decreased Beclin-1 expression, and the activity of macrophages, may be associated with chemotherapy resistance and poor prognoses in patients with ovarian cancer. This evidence concerns the gene BECN1 and ovarian cancer.